# Spain Gamma Knife Market > Spain Gamma Knife Market Research Report: Size, Share, Trend Analysis By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others) and By Anatomy (Head, Neck, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.83% - **2024:** $ 11.15 Million - **2025:** $ 11.8 Million - **2035:** $ 20.8 Million - **Key Players:** Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Nicolet Biomedical (US), Shenzhen Huikang Medical (CN), ZhuHai Huarui Medical (CN) **Report ID:** MRFR/HC/50660-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/spain-gamma-knife-market-52418 --- ## Market Summary ## **Spain Gamma Knife Market Overview** As per MRFR analysis, the Spain Gamma Knife Market Size was estimated at 9.32 (USD Million) in 2024.The Spain Gamma Knife Market Industry is expected to grow from 9.8(USD Million) in 2025 to 17 (USD Million) by 2035. The Spain Gamma Knife Market CAGR (growth rate) is expected to be around 5.135% during the forecast period (2025 - 2035) **Key Spain Gamma Knife Market Trends Highlighted** The Spain Gamma Knife Market is experiencing a notable shift towards advanced radiation therapy techniques, reflecting a broader trend in the medical field. With a growing emphasis on non-invasive treatments, healthcare providers in Spain are increasingly adopting Gamma Knife technology for its precision in treating brain tumors and other neurological disorders. This trend is driven by the rising incidence of cancer and brain-related conditions in the region, pushing for innovative treatment options. The Spanish government is investing in healthcare infrastructure, which supports the implementation of cutting-edge medical technologies.  There are significant opportunities to be explored in the realm of research and partnerships.Collaboration between public hospitals and private sector entities could enhance the availability of Gamma Knife services across Spain. Training programs for healthcare professionals are also crucial in maximizing the effectiveness of these technologies, thereby improving patient outcomes. In recent times, Spain has seen an increase in awareness regarding the benefits of stereotactic radiosurgery, enhancing the adoption of Gamma Knife systems in specialized centers.  Furthermore, the establishment of new cancer treatment centers has bolstered the market, ensuring that more patients have access to this advanced therapy. Telemedicine and digital health initiatives are also on the rise, enabling better patient management and follow-up care post-treatment, which creates a fertile ground for the growth of the Gamma Knife market in Spain. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Spain Gamma Knife Market Drivers** **Rising Incidence of Cancer in Spain** The increasing incidence of cancer in Spain significantly drives the Spain Gamma Knife Market Industry. According to data from the Spanish Association Against Cancer, the incidence of cancer is projected to rise. For instance, nearly 1 out of 2 men and 1 out of 3 women in Spain are anticipated to develop cancer during their lifetime. This clear uptick in cancer cases, particularly brain tumors, has led to an increasing demand for effective treatment options such as Gamma Knife radiosurgery.The technology offers a non-invasive alternative to traditional surgery, appealing to both patients and healthcare providers as a viable option for treating complex brain conditions.  The integration of Gamma Knife technology in Spanish healthcare facilities is likely to expand that market's accessibility. Furthermore, the continuous research conducted by organizations such as the National Cancer Research Center in Spain has paved the way for improved understanding and management of cancer, directly supporting the growth of the Spain Gamma Knife Market Industry. **Technological Advancements in Gamma Knife Treatments** Innovations in medical technology play a crucial role in enhancing the effectiveness and efficiency of Gamma Knife treatments, propelling the Spain Gamma Knife Market Industry. The development of advanced imaging techniques and improved software systems has led to more precise targeting capabilities in Gamma Knife procedures. The University Hospital of La Paz in Madrid has incorporated cutting-edge technology that allows for real-time imaging and treatment planning, significantly improving treatment accuracy.Such advancements are essential as they directly correlate with better patient outcomes, increasing the acceptance and implementation of Gamma Knife technology across healthcare institutions in Spain. Moreover, intellectual property filings related to medical technology innovations in this field indicate an ongoing commitment to research and development, further ensuring sustained market growth in the future. **Government Initiatives Supporting Healthcare Infrastructure** The Spanish government is focusing on enhancing healthcare infrastructure, directly influencing the growth of the Spain Gamma Knife Market Industry. The Spanish Ministry of Health has launched initiatives aimed at upgrading medical facilities and expanding access to advanced cancer treatments. For instance, the 'Health Strategy 2022-2024' plan emphasizes increasing funding for the modernization of hospitals, which includes the acquisition of state-of-the-art equipment such as Gamma Knife systems. Because the government is investing in the healthcare sector, and as the number of brain cancer cases increases, this positively impacts the adoption of Gamma Knife technology in hospitals across Spain. This funding assists in guaranteeing that an increasing number of patients receive sophisticated care in a timely manner, thus supporting market expansion. **Growing Awareness and Acceptance of Non-Invasive Treatment Options** There is a significant increase in patient awareness regarding non-invasive treatment options like Gamma Knife radiosurgery in Spain, contributing to the growth of the Spain Gamma Knife Market Industry. The proliferation of health campaigns and educational programs by healthcare organizations has helped inform patients about the benefits of non-invasive procedures, emphasizing their short recovery times and minimal side effects.  As reported by the Spanish Society of Medical Oncology, patient preference is increasingly shifting toward non-invasive treatments for brain tumors.This growing acceptance encourages healthcare providers to offer more Gamma Knife treatments, thereby boosting the market. Furthermore, successful case studies and testimonials from universities and hospitals throughout Spain highlight the effectiveness of this technology, driving further interest and investment in Gamma Knife systems. **Spain Gamma Knife Market Segment Insights** **Gamma Knife Market Disease Indication Insights** The Spain Gamma Knife Market derived from the Disease Indication segment reveals a robust landscape characterized by various therapeutic applications crucial for enhancing patient care in neurosurgery. Brain metastasis represents a significant portion of the market, primarily due to the rising incidence of cancers that tend to spread to the brain, thus emphasizing the need for effective localized treatments like Gamma Knife radiosurgery.  This method provides a non-invasive solution, making it particularly appealing in the Spanish healthcare context where personalized medicine is becoming more prevalent. Cancer, in general, contributes notably to the demand for Gamma Knife procedures, as these interventions offer precise targeting while minimizing damage to surrounding healthy tissues, a critical factor in effective treatment protocols. Arteriovenous malformation also holds considerable relevance within this space; its treatment via Gamma Knife is increasingly recognized for its ability to facilitate safe and effective management, thus addressing complex vascular anomalies that can lead to severe complications such as hemorrhage. Trigeminal neuralgia, another condition treated effectively with Gamma Knife technology, affects many individuals and can significantly impact their quality of life.  The use of targeted therapies for this condition not only alleviates pain but also reflects the advancements within the Spanish healthcare system towards innovative and effective treatment modalities that enhance patient outcomes. Furthermore, the 'Others' category encompasses a variety of other neurological conditions that might benefit from Gamma Knife technology, showcasing its versatility and broad applicability across different indications. The Spain Gamma Knife Market continues to evolve as the country's healthcare infrastructure upgrades and more professionals recognize the benefits of minimally invasive treatment options. Market statistics highlight a growing acceptance among clinicians and patients alike, driven by increasing awareness of treatment efficacy and enhanced patient survival rates. Regulatory support and advancements in gamma technology continue to fuel market growth, ensuring that this segment remains pivotal in the Spain Gamma Knife Market landscape.  Overall, the Disease Indication segment highlights the increasing significance of Gamma Knife radiosurgery as a vital component of modern neurological treatment strategies, aligning with Spain's commitment to high-quality healthcare services. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Gamma Knife Market Anatomy Insights** The Spain Gamma Knife Market focused on the Anatomy segment is evolving, reflecting the increasing demand for precise and non-invasive treatment options for neurological conditions. Within this scope, the market is divided into areas concerning the Head, Neck, and Other anatomical regions, each contributing to the overall growth trajectory of the industry. The Head segment, particularly critical in the treatment of brain tumors and vascular malformations, highlights a significant demand for advanced technology. This leads to improved patient outcomes and showcases the efficacy of Gamma Knife procedures.The Neck segment addresses conditions affecting seminal nerves and cervical spine disorders, reinforcing its importance in holistic treatment approaches in Spain.  Additionally, the Others category encompasses various anatomical areas that require specialized treatment, thus addressing a variety of patient needs and conditions. The growing prevalence of neurological disorders and the push for minimally invasive treatments are key driving factors in the market. Furthermore, the advancements in technology and increased healthcare funding in Spain facilitate market growth, creating numerous opportunities for innovation and enhancement of existing treatment protocols. **Spain Gamma Knife Market Key Players and Competitive Insights** The Spain Gamma Knife Market is characterized by a diverse and competitive landscape that comprises various players focused on advanced radiation therapy for treating brain tumors and other neurological conditions. Gamma Knife technology is renowned for its precision and minimal invasiveness, which has significantly heightened its adoption among healthcare facilities in Spain. The market dynamics are shaped by factors including technological advancements, regulatory frameworks, and the increasing prevalence of neurological disorders.  Additionally, partnerships and collaborations among healthcare providers and technology developers play a crucial role in enhancing the capabilities and reach of Gamma Knife services across the country. Such competitive insights enable stakeholders to strategize effectively to gain a better foothold in the growing market.Cleveland Clinic has a formidable presence in the Spain Gamma Knife Market, primarily owing to its reputation for high-quality patient care and innovative treatment methodologies. The institution leverages its extensive experience in neurosurgery and radiation oncology to deliver optimal outcomes using Gamma Knife technology.  Cleveland Clinic's strengths include a team of experienced specialists, cutting-edge facilities, and a dedicated approach to patient-centered care. The clinic's commitment to continual medical research and education also positions it favorably within the competitive landscape, enabling it to stay ahead in the adoption and application of the latest advancements in Gamma Knife treatments, thus enhancing its service offerings in the Spain region.CitiusTech also plays a significant role in the Spain Gamma Knife Market, focusing on the integration of advanced healthcare technology solutions that support Gamma Knife applications.  This company’s primary strength lies in its comprehensive healthcare IT services that streamline workflows and improve patient management in facilities utilizing Gamma Knife systems. CitiusTech is known for its innovative products aimed at enhancing operational efficiencies, patient data management, and analytics in radiation therapy contexts. The company has pursued strategic partnerships and potential mergers in Spain to bolster its market presence, allowing it to provide tailored solutions that meet local healthcare demands. Their focus on improving patient outcomes and optimizing service efficiency positions CitiusTech as a vital player in the evolving Gamma Knife landscape in Spain, facilitating better accessibility and utilization of advanced treatment options. **Key Companies in the Spain Gamma Knife Market Include** **Spain Gamma Knife Market Industry Developments** In recent times, the Spain Gamma Knife Market has witnessed a series of significant developments. There has been a noted interest in advanced cancer treatment technologies, particularly in the utilization of Gamma Knife radiosurgery for brain tumors. Hospitals and clinics such as Johns Hopkins Medicine and Cleveland Clinic are enhancing their offerings in this sector. In September 2023, GE Healthcare announced a strategic partnership aimed at advancing the research capabilities related to Gamma Knife technology and improving patient outcomes in Spain.  Furthermore, during the last two years, key players like Elekta and Varian Medical Systems have reported growth in their market valuations, positively influencing the competitive landscape. In March 2022, Siemens Healthineers expanded its operations in Spain, reflecting ongoing investment in cutting-edge medical technologies. These developments are indicative of a strong commitment to enhancing cancer care in Spain, with organizations like CitiusTech and Mayo Clinic also exploring collaborative opportunities in the Gamma Knife arena.  Overall, the Spanish healthcare system is adapting to advance its technologies, catering to a rising demand for non-invasive treatment options. **Spain Gamma Knife Market Segmentation Insights** ## Market Drivers ### Supportive Regulatory Environment The regulatory environment in Spain is becoming increasingly supportive of innovative medical technologies, including gamma knife systems. Regulatory bodies are streamlining the approval processes for new medical devices, which facilitates quicker access to advanced treatment options for patients. This supportive framework encourages manufacturers to invest in research and development, leading to the introduction of more efficient gamma knife systems. As a result, the gamma knife market is expected to thrive, as healthcare providers gain access to cutting-edge technologies that enhance patient care and treatment efficacy. ### Rising Incidence of Brain Disorders The gamma knife market in Spain is experiencing growth due to the increasing incidence of brain disorders such as tumors and vascular malformations. According to recent health statistics, brain tumors account for approximately 2.5% of all cancers diagnosed in Spain, leading to a heightened demand for effective treatment options. The non-invasive nature of gamma knife surgery makes it an appealing choice for both patients and healthcare providers. As the population ages, the prevalence of neurological conditions is likely to rise, further driving the need for advanced treatment modalities. This trend suggests that the gamma knife market will continue to expand as healthcare facilities seek to adopt innovative technologies to address these challenges. ### Growing Awareness of Treatment Options There is a notable increase in public awareness regarding treatment options for brain disorders in Spain, which is positively influencing the gamma knife market. Educational campaigns and outreach programs by healthcare organizations have contributed to a better understanding of non-invasive procedures. As patients become more informed about the benefits of gamma knife surgery, including shorter recovery times and reduced side effects, the demand for such treatments is likely to rise. This shift in patient preferences indicates a potential growth trajectory for the gamma knife market, as healthcare providers adapt to meet the evolving needs of their patients. ### Investment in Healthcare Infrastructure Spain's commitment to enhancing its healthcare infrastructure is a significant driver for the gamma knife market. The government has allocated substantial funding to modernize hospitals and medical facilities, which includes the acquisition of advanced medical equipment like gamma knife systems. Reports indicate that healthcare spending in Spain is projected to grow by approximately 4% annually, reflecting a strong focus on improving patient care. This investment not only facilitates the adoption of cutting-edge technologies but also ensures that healthcare providers can offer state-of-the-art treatments. Consequently, the gamma knife market is poised to benefit from this trend as more facilities integrate these systems into their treatment offerings. ### Technological Integration in Medical Practices The integration of advanced technologies in medical practices is a crucial factor driving the gamma knife market in Spain. The advent of sophisticated imaging techniques, such as MRI and CT scans, enhances the precision of gamma knife procedures, making them more effective. Hospitals are increasingly adopting these technologies to improve treatment outcomes, which in turn boosts the demand for gamma knife systems. The gamma knife market is likely to see continued growth as medical professionals leverage these innovations to provide high-quality care. This trend underscores the importance of technological advancements in shaping the future of treatment options available to patients. ## Future Outlook The [Gamma Knife Market](https://www.marketresearchfuture.com/reports/gamma-knife-market-19189) in Spain is projected to grow at a 5.83% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for non-invasive treatments. **New opportunities:** - Expansion of telemedicine services for remote consultations - Development of advanced imaging integration with gamma knife systems - Partnerships with healthcare providers for bundled treatment packages By 2035, the gamma knife market is expected to achieve robust growth and enhanced market presence. ## Segment Insights ### By Disease Indication: Brain Metastasis (Largest) vs. Trigeminal Neuralgia (Fastest-Growing) The Spain gamma knife market showcases a diverse set of disease indications, with Brain Metastasis dominating the landscape. This segment holds a significant share due to the rising incidence of metastatic brain tumors among cancer patients. Following closely are Arteriovenous Malformations, which continue to garner attention due to advancements in treatment protocols. Trigeminal Neuralgia, while currently smaller in share, is witnessing increased demand for effective non-invasive treatment options, driving notable interest in this area. As treatment options evolve, the growth trajectory of Trigeminal Neuralgia appears particularly promising, attributed to an aging population and increased awareness of this condition. Meanwhile, Cancer remains a key driver considering the ongoing battle against various cancers, leading to sustained investments in gamma knife technologies. As healthcare providers and patients increasingly prefer minimally invasive solutions, segments like Trigeminal Neuralgia are poised for rapid growth in the coming years. Brain Metastasis (Dominant) vs. Trigeminal Neuralgia (Emerging) Brain Metastasis represents the dominant segment in the Spain gamma knife market, characterized by a high prevalence of secondary brain cancers requiring precise, targeted therapies. The increasing volume of cancer cases contributes to steady demand in this area. Clinicians favor gamma knife radiotherapy for its precision and effectiveness, making it a reliable treatment option for Brain Metastasis. Conversely, Trigeminal Neuralgia is emerging as a significant niche within the market as awareness of its painful symptoms escalates. Patients are increasingly seeking out non-invasive treatments, positioning this segment for robust growth. The convergence of technological advancements and rising patient awareness is creating a fertile environment for the expansion of emerging indications like Trigeminal Neuralgia. ### By Anatomy: Head (Largest) vs. Neck (Fastest-Growing) In the Spain gamma knife market, the distribution of market share among different anatomical segments reveals that the Head segment holds the largest share. This dominance can be attributed to the high incidence of conditions treated in this area, emphasizing the necessity for advanced treatments such as gamma knife procedures. The Neck segment, while currently smaller, is rapidly gaining traction, reflecting an increasing inclination towards targeted therapies for neck-related conditions. Growth trends in the Spain gamma knife market indicate that advancements in technology and increasing awareness among healthcare professionals are driving the expansion of the Neck segment. The gamma knife's non-invasive nature and effective outcomes have made it a preferred choice for patients, leading to its recognition as the fastest-growing segment. As treatment protocols evolve, the focus on anatomical precision and patient-centered care will further boost the market's growth in both segments. Anatomy: Head (Dominant) vs. Neck (Emerging) The Head segment, being the dominant force in the gamma knife market, is characterized by its extensive applications in treating various cranial conditions such as tumors and vascular malformations. This segment benefits from a well-established presence in healthcare facilities, supported by a proven track record of successful outcomes that engender confidence among medical professionals. On the other hand, the Neck segment is emerging as a formidable player, driven by innovations in treatment practices and an increasing recognition of neck conditions. The non-invasive attributes of gamma knife procedures appeal to patients seeking effective alternatives to traditional surgery, positioning the Neck segment for significant growth and adoption in the coming years. ## Competitive Benchmarking The gamma knife market in Spain is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Elekta AB (SE), Accuray Incorporated (US), and Varian Medical Systems (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Elekta AB (SE) focuses on technological advancements in stereotactic radiosurgery, emphasizing the development of next-generation gamma knife systems that improve treatment precision and patient outcomes. Meanwhile, Accuray Incorporated (US) is leveraging its expertise in adaptive radiation therapy, which allows for personalized treatment plans, thereby appealing to a broader patient demographic. Varian Medical Systems (US) is also notable for its commitment to integrating artificial intelligence (AI) into its treatment planning processes, which enhances operational efficiency and treatment accuracy. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and technological prowess are paramount.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share while also collaborating through strategic alliances. This fragmentation allows for a diverse range of products and services, catering to various patient needs and preferences. The influence of key players is significant, as their strategic decisions often set the tone for market trends and consumer expectations. In October Elekta AB (SE) announced a partnership with a leading Spanish healthcare provider to implement its latest gamma knife technology across multiple treatment centers. This collaboration is expected to enhance patient access to advanced radiosurgery options, thereby solidifying Elekta's position in the Spanish market. The strategic importance of this partnership lies in its potential to increase market penetration and improve treatment outcomes, aligning with the growing demand for innovative healthcare solutions. In September Accuray Incorporated (US) launched a new software update for its CyberKnife system, which includes enhanced imaging capabilities and treatment planning features. This update is particularly significant as it reflects Accuray's commitment to continuous improvement and adaptation to evolving clinical needs. By enhancing the functionality of its existing systems, Accuray aims to retain its competitive edge and attract new customers seeking state-of-the-art treatment options. In August Varian Medical Systems (US) expanded its operations in Spain by establishing a new training center focused on educating healthcare professionals on the latest advancements in radiation therapy. This initiative underscores Varian's dedication to fostering a knowledgeable workforce capable of utilizing advanced technologies effectively. The establishment of this center is likely to enhance Varian's reputation and strengthen its relationships with healthcare providers, ultimately driving sales and market share. As of November current competitive trends in the gamma knife market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a crucial role in shaping the landscape, as companies collaborate to enhance their technological capabilities and expand their service offerings. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will likely emerge as leaders in the market. ## Recent News & Developments In recent times, the Spain Gamma Knife Market has witnessed a series of significant developments. There has been a noted interest in advanced cancer treatment technologies, particularly in the utilization of Gamma Knife radiosurgery for brain tumors. Hospitals and clinics such as Johns Hopkins Medicine and Cleveland Clinic are enhancing their offerings in this sector. In September 2023, GE Healthcare announced a strategic partnership aimed at advancing the research capabilities related to Gamma Knife technology and improving patient outcomes in Spain.  Furthermore, during the last two years, key players like Elekta and Varian Medical Systems have reported growth in their market valuations, positively influencing the competitive landscape. In March 2022, Siemens Healthineers expanded its operations in Spain, reflecting ongoing investment in cutting-edge medical technologies. These developments are indicative of a strong commitment to enhancing cancer care in Spain, with organizations like CitiusTech and Mayo Clinic also exploring collaborative opportunities in the Gamma Knife arena.  Overall, the Spanish healthcare system is adapting to advance its technologies, catering to a rising demand for non-invasive treatment options. ## Report Scope | MARKET SIZE 2024 | 11.15(USD Million) | | --- | --- | | MARKET SIZE 2025 | 11.8(USD Million) | | MARKET SIZE 2035 | 20.8(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.83% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Nicolet Biomedical (US), Shenzhen Huikang Medical (CN), ZhuHai Huarui Medical (CN) | | Segments Covered | Disease Indication, Anatomy | | Key Market Opportunities | Advancements in precision oncology drive growth in the gamma knife market. | | Key Market Dynamics | Rising demand for advanced cancer treatments drives innovation and competition in the gamma knife market. | | Countries Covered | Spain | ## Frequently Asked Questions **Q: What was the overall market valuation of the gamma knife market in Spain in 2024?** A: The overall market valuation was $11.15 Million in 2024. **Q: What is the projected market valuation for the gamma knife market in Spain by 2035?** A: The projected valuation for 2035 is $20.8 Million. **Q: What is the expected CAGR for the gamma knife market in Spain during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 5.83%. **Q: Which companies are considered key players in the Spain gamma knife market?** A: Key players include Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, MediTech, Nicolet Biomedical, Shenzhen Huikang Medical, and ZhuHai Huarui Medical. **Q: What are the primary disease indications for gamma knife treatments in Spain?** A: Primary disease indications include Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, and Others. **Q: What was the market valuation for Brain Metastasis in the Spain gamma knife market in 2024?** A: The market valuation for Brain Metastasis was $2.5 Million in 2024. **Q: What is the projected market valuation for Cancer treatment in the Spain gamma knife market by 2035?** A: The projected market valuation for Cancer treatment by 2035 is $5.5 Million. **Q: How does the market valuation for Trigeminal Neuralgia compare to other disease indications in 2024?** A: In 2024, the market valuation for Trigeminal Neuralgia was $2.0 Million, which is lower than Brain Metastasis and Cancer. **Q: What anatomical areas are primarily targeted in the Spain gamma knife market?** A: The primary anatomical areas targeted include Head, Neck, and Others. **Q: What was the market valuation for the Head anatomical area in the Spain gamma knife market in 2024?** A: The market valuation for the Head anatomical area was $4.5 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spain-gamma-knife-market-52418*